[{"address1": "175 Innovation Boulevard", "city": "Wilmington", "state": "DE", "zip": "19805", "country": "United States", "phone": "302 467 1280", "website": "https://preludetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Krishna  Vaddi D.V.M., Ph.D.", "age": 58, "title": "Founder, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 881092, "exercisedValue": 0, "unexercisedValue": 12515}, {"maxAge": 1, "name": "Dr. Edna  Huang M.D.", "age": 51, "title": "President & Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 843233, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bryant David Lim J.D.", "age": 53, "title": "CFO, Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 621017, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Aimee  Crombie Ph.D.", "title": "Senior VP and Head of Strategic Planning & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Madhu  Pudipeddi Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peggy A. Scherle Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 868617, "exercisedValue": 0, "unexercisedValue": 436567}, {"maxAge": 1, "name": "Ms. Michele  Porreca M.B.A.", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew P. Combs Ph.D.", "age": 57, "title": "Executive VP & Chief Chemistry Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 562461, "exercisedValue": 0, "unexercisedValue": 399432}, {"maxAge": 1, "name": "Mr. Naveen  Babbar Ph.D.", "title": "Senior Vice President of Translation Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wan-Jen  Hong M.D.", "age": 45, "title": "Senior Vice President of Clinical Development", "yearBorn": 1979, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.31, "open": 1.3, "dayLow": 1.17, "dayHigh": 1.35, "regularMarketPreviousClose": 1.31, "regularMarketOpen": 1.3, "regularMarketDayLow": 1.17, "regularMarketDayHigh": 1.35, "payoutRatio": 0.0, "beta": 1.273, "forwardPE": -0.7880795, "volume": 173064, "regularMarketVolume": 173064, "averageVolume": 218918, "averageVolume10days": 194280, "averageDailyVolume10Day": 194280, "bid": 1.12, "ask": 1.26, "bidSize": 2, "askSize": 2, "marketCap": 67354416, "fiftyTwoWeekLow": 0.61, "fiftyTwoWeekHigh": 1.93, "allTimeHigh": 95.375, "allTimeLow": 0.61, "priceToSalesTrailing12Months": 9.62206, "fiftyDayAverage": 1.18614, "twoHundredDayAverage": 0.964385, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 35298716, "profitMargins": 0.0, "floatShares": 29173225, "sharesOutstanding": 43750086, "sharesShort": 601130, "sharesShortPriorMonth": 531205, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.0106, "heldPercentInsiders": 0.113570005, "heldPercentInstitutions": 0.62315, "shortRatio": 2.33, "shortPercentOfFloat": 0.0799, "impliedSharesOutstanding": 56600345, "bookValue": 0.996, "priceToBook": 1.1947792, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -124318000, "trailingEps": -1.64, "forwardEps": -1.51, "enterpriseToRevenue": 5.043, "enterpriseToEbitda": -0.265, "52WeekChange": -0.33146065, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 1.19, "targetHighPrice": 5.0, "targetLowPrice": 1.0, "targetMeanPrice": 3.5, "targetMedianPrice": 4.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 73216000, "totalCashPerShare": 0.962, "ebitda": -133245000, "totalDebt": 17917000, "quickRatio": 3.502, "currentRatio": 3.677, "totalRevenue": 7000000, "debtToEquity": 23.625, "revenuePerShare": 0.092, "returnOnAssets": -0.49751, "returnOnEquity": -0.96328, "grossProfits": 7000000, "freeCashflow": -68643376, "operatingCashflow": -108346000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -19.28671, "financialCurrency": "USD", "symbol": "PRLD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1760743890, "regularMarketTime": 1760731200, "exchange": "NMS", "messageBoardId": "finmb_373775974", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -9.1603, "regularMarketPrice": 1.19, "postMarketChangePercent": 0.0, "postMarketPrice": 1.19, "postMarketChange": 0.0, "regularMarketChange": -0.12, "regularMarketDayRange": "1.17 - 1.35", "fullExchangeName": "NasdaqGS", "shortName": "Prelude Therapeutics Incorporat", "longName": "Prelude Therapeutics Incorporated", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601040600000, "averageDailyVolume3Month": 218918, "fiftyTwoWeekLowChange": 0.58000004, "fiftyTwoWeekLowChangePercent": 0.95081973, "fiftyTwoWeekRange": "0.61 - 1.93", "fiftyTwoWeekHighChange": -0.7399999, "fiftyTwoWeekHighChangePercent": -0.38341963, "fiftyTwoWeekChangePercent": -33.146065, "earningsTimestamp": 1755174600, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.64, "epsForward": -1.51, "epsCurrentYear": -1.37, "priceEpsCurrentYear": -0.8686132, "fiftyDayAverageChange": 0.003860116, "fiftyDayAverageChangePercent": 0.0032543512, "twoHundredDayAverageChange": 0.22561508, "twoHundredDayAverageChangePercent": 0.23394711, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-25", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]